Institutional investors control 22.72% of the outstanding shares in ZIOP. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended December 2014, these large investors purchased a net $2.0 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MSDC MANAGEMENT LP Bought 1.4 Million shares of ZIOPHARM Oncology Inc
BELMONT GLOBAL ADVISORS, INC. Bought 653.0 Thousand shares of ZIOPHARM Oncology Inc
BLACKROCK FUND ADVISORS Bought 540.1 Thousand shares of ZIOPHARM Oncology Inc